Equity Capital Markets

Company · CIK 1827506

Tourmaline Bio, Inc.

CIK1827506 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressNY
Listedno ticker on SEC record today
First annual or quarterly report2021-06-14

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-255316
IPOFinal prospectus
 2021-04-162025-11-145
333-283078
ShelfEffective
 2024-11-072025-11-143
333-266875
ShelfEffective
 2022-08-152024-01-264

Filings

14
FiledFilingRegistrationAccession
2025-11-14EFFECTDeclared effective 333-2830789999999995-25-003289
2025-11-14EFFECTDeclared effective 333-2553169999999995-25-003283
2024-11-14EFFECTDeclared effective 333-2830789999999995-24-003490
2024-11-07S-3Shelf registered 333-2830780001827506-24-000099
2024-01-26424B5Shelf takedown 333-2668750001193125-24-016713
2024-01-25424B5Shelf takedown 333-2668750001193125-24-014541
2023-09-14EFFECTDeclared effective 333-2733359999999995-23-002663
2022-08-25EFFECTDeclared effective 333-2668759999999995-22-002502
2022-08-15S-3Shelf registered 333-2668750001193125-22-221286
2021-05-10424B4Final prospectus 333-2553160001193125-21-156269
2021-05-06EFFECTDeclared effective 333-2553169999999995-21-001826
2021-05-03S-1/AAmendment 333-2553160001193125-21-146474
2021-04-16S-1Registration filed 333-2553160001193125-21-119531
2021-02-26DRSDraft made public 377-043190000950123-21-003174

All filings of this company · CSV